http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2013003487-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcb004f4cdc56d81da7e896b2e1d8eb6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20
filingDate 2013-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e98192afc08ebd87bb40c7ab3722fcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e6022f1594b3d6879a5583d92520006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de1971f6784ae952d33195770c9014bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bc2ad7ebb6a1ab5183efd3dd5aa9ad4
publicationDate 2014-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2013003487-A1
titleOfInvention Use of a compound derived from nucleoside phosphoramidate to treat dengue fever and specific compounds.
abstract THIS APPLICATION PROVIDES THE USE OF A NUCLOSED PHOSPHORAMIDATE DERIVATIVE COMPOSITE TO TREAT FEVER DENGUE. IN ADDITION, SPECIFIC COMPOUNDS DERIVED FROM NUCLOSIDE PHOSPHORAMIDATE ARE DESCRIBED.
priorityDate 2011-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID211207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584773

Total number of triples: 35.